ENSG vs. PACS, HQY, CYTK, EXEL, ELAN, PCVX, JAZZ, GMED, ACHC, and INSP
Should you be buying The Ensign Group stock or one of its competitors? The main competitors of The Ensign Group include PACS Group (PACS), HealthEquity (HQY), Cytokinetics (CYTK), Exelixis (EXEL), Elanco Animal Health (ELAN), Vaxcyte (PCVX), Jazz Pharmaceuticals (JAZZ), Globus Medical (GMED), Acadia Healthcare (ACHC), and Inspire Medical Systems (INSP). These companies are all part of the "medical" sector.
PACS Group (NYSE:PACS) and The Ensign Group (NASDAQ:ENSG) are both mid-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation, institutional ownership and community ranking.
The Ensign Group has a net margin of 5.61% compared to The Ensign Group's net margin of 0.00%. PACS Group's return on equity of 17.84% beat The Ensign Group's return on equity.
The Ensign Group received 350 more outperform votes than PACS Group when rated by MarketBeat users.
The Ensign Group has higher revenue and earnings than PACS Group.
In the previous week, PACS Group had 4 more articles in the media than The Ensign Group. MarketBeat recorded 9 mentions for PACS Group and 5 mentions for The Ensign Group. The Ensign Group's average media sentiment score of 0.16 beat PACS Group's score of 0.01 indicating that PACS Group is being referred to more favorably in the media.
The Ensign Group has a consensus target price of $123.60, suggesting a potential upside of 4.43%. Given PACS Group's higher probable upside, analysts clearly believe The Ensign Group is more favorable than PACS Group.
96.1% of The Ensign Group shares are held by institutional investors. 3.9% of The Ensign Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Summary
The Ensign Group beats PACS Group on 10 of the 12 factors compared between the two stocks.
Get The Ensign Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for ENSG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ENSG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
The Ensign Group Competitors List
Related Companies and Tools
